Natural gas has been an investment darling for some time now, but environmentalists have had decidedly mixed feelings for this relatively new energy source. While, on the one hand, natural gas emits far less greenhouse gas than do coal and oil, it's still a fossil fuel that contributes more to climate change than do clean energy sources such as wind and solar. The jury is still out on the safety of fracking, too. Because the energy investment case is so deeply linked to climate matters, long-term investors would be foolish to ignore these concerns.
Fortunately, there's a strong framework within which natural gas would keep greenhouse gas emissions low and portfolio returns high for years to come. The Center for Climate and Energy Solutions (C2ES) published a report recently that analyzes the climate challenges and opportunities the natural gas boom poses.�"Leveraging Natural Gas to Reduce Greenhouse Gas Emissions" spells out how natural gas can be a tool for constraining climate change, so long as additional measures are pursued in tandem.
Westinghouse Air Brake Technologies Corporation (Wabtec), doing business as Wabtec Corporation, is a providers of value-added, technology-based equipment and services for the global rail industry. It provides its products and services through two business segments: the Freight Group and the Transit Group, both of which have different market characteristics and business drivers. Effective November 18, 2011, Wabtec acquired Fulmer Company, a manufacturer of motor components for rail, power generation and other industrial markets. Effective November 3, 2011, Wabtec acquired Bearward Engineering, a manufacturer of cooling systems and related equipment for power generation and other industrial markets. On June 29, 2011, the Company acquired an aftermarket transit parts business from GE Transportation, a parts supply business for propulsion and control systems for the passenger transit car aftermarket in North America. On February 25, 2011, the Company acquired Brush Traction Group, a provider of locomotive overhauls, services and aftermarket components. In July 2012, it acquired Tec Tran Corp. and its affiliates. In October 2012, it acquired LH Group. Effective July 30, 2013, Westinghouse Air Brake Technologies Corp acquired Turbonetics Inc, a manufacturer of turbochargers and components. Effective September 24, 2013, Westinghouse Air Brake Technologies Corp acquired Longwood Industries Inc.
The Freight Group manufactures and services components for freight cars and locomotives, builds new switcher locomotives, rebuilds freight locomotives, supplies railway electronics, positive train control equipment, signal design and engineering services, and provides related heat exchange and cooling systems. Its customers include railroads, leasing companies, manufacturers of original equipment, such as locomotives and freight cars, and utilities. During the year ended December 31, 2011, the Freight Group accounted for 61% of its total sales, with about 75% of its sales in North America and the remainder! to international customers.
The Transit Group manufactures and services components for new and existing passenger transit vehicles, which include subway cars and buses, builds new commuter locomotives and refurbishes subway cars. Customers include public transit authorities and municipalities, leasing companies, and manufacturers of subway cars and buses globally. During 2011, the Transit Group accounted for 39% of its total sales, with about half of its sales in North America and the remainder to international customers. During 2011, about 66% of the Transit Group�� sales are in the aftermarket and the remainder in the original equipment market.
The Company�� specialty products and electronics include positive train control equipment and electronically controlled pneumatic braking products; railway electronics, including event recorders, monitoring equipment and end of train devices; signal design and engineering services; freight car truck components; draft gears, couplers and slack adjusters; air compressors and dryers; heat exchangers and cooling products for locomotives and power generation equipment, and track and switch products. Its brake products include railway braking equipment and related components for freight and transit applications, and friction products, including brake shoes and pads. Its remanufacturing, overhaul and build products include new commuter and switcher locomotives, and transit car and locomotive overhaul and refurbishment. Its transit products include rail and bus door and window assemblies; accessibility lifts and ramps for buses and subway cars, and traction motors.
The Company competes with Knorr-Bremse AG, Electro-Motive Diesel, GE Transportation Systems and Faiveley Transport.
Advisors' Opinion: - [By Rich Duprey]
The board of directors of railroad products manufacturer Wabtec (NYSE: WAB ) was busy yesterday, announcing it was increasing its quarterly dividend payment by 60% while simultaneously splitting the company's stock.
- [By Holly LaFon]
Another area that is intriguing to us is the North American energy sector which looks to have a number of interesting catalysts currently. While the energy sector is at present only a modest overweight in the portfolios, we have been encouraged by several trends taking place for a number of years. These positive developments are also having an impact that goes far beyond the energy sector itself. Many believe that the U.S. will become energy independent and possibly a net exporter of natural gas and oil (currently restricted by law) in the next decade. This opinion is based primarily on the development of new drilling techniques (i.e. horizontal drilling, and high pressure fracking) that have enabled companies to access oil and natural gas reserves in shale formations that were previously not economically viable. The ability to tap into this acreage is a game-changer in our view and is already having a tremendous impact on the economy. Employment rates in these mostly rural areas surrounding the shale basins are very high and companies thus find hiring extremely competitive. Strong labor markets tend to create strong local economies. Oil States International (OIS) has been able to capitalize on this trend by providing housing and other services to oil service workers that are in demand in the area. CST Brands (CST) operates gas stations in Texas, but it is increasingly looking to broaden its product offering beyond fuel. Rail companies like Union Pacific (UNP), Canadian Pacific (CP), Kansas City Southern (KSU) and Genesee and Wyoming (GWR) have also benefited substantially. Given that shale areas are rural and often lacking infrastructure, substantial investment must be made to support drilling and production activities. Without pipelines in place, railroads have been the primary takeaway mechanism for moving production to the various clusters of refining capacity around the United States. In order to serve this demand, massive investment in railcars has been nee
Best Clean Energy Companies To Own For 2015: VisionChina Media Inc.(VISN)
VisionChina Media Inc., through its subsidiaries, provides advertising services in the People?s Republic of China. The company operates out-of-home advertising network using real-time mobile digital television broadcasts to deliver content and advertising on mass transportation systems. Its mobile digital television advertising network delivers real-time content provided by the local television stations. The company?s network also displays real-time news and stock quotes, weather and traffic updates, sports highlights, and other programs, as well as disseminates public-interest messages and programs that promote the general welfare of society and other urgent messages during emergency situations, such as typhoons, earthquakes, and other events that concern public safety. Its advertising network consists of digital television displays primarily located on buses, and in subway trains and subway platforms that receive mobile digital television broadcasts of real-time conten t and advertising. The company also operates various closed-circuit advertising digital displays in subway platforms and subway trains in Beijing, Chongqing, Guangzhou, Nanjing, Shenzhen, and Tianjin, as well as in subway trains in Hong Kong. As of December 31, 2010, its network and supplemental subway advertising platform covered 23 cities in China and consisted of approximately 137,395 digital displays. The company sells its advertising time through direct sales force and third party advertising agencies. VisionChina Media Inc. was founded in 2005 and is headquartered in Shenzhen, the People?s Republic of China.
Advisors' Opinion: - [By Monica Gerson]
VisionChina Media (NASDAQ: VISN) surged 31.25% to $31.75 in the pre-market session after the company announced an exclusive strategic cooperation with Baidu Games.
- [By Monica Gerson]
VisionChina Media (NASDAQ: VISN) soared 5.13% to $32.80 in the pre-market trading. VisionChina's trailing-twelve-month revenue is $98.39 million.
The Dow Chemical Company (NYSE: DOW) surged 0.90% to $45.00 in the pre-market session. Dow Chemical's trailing-twelve-month revenue is $56.61 billion.
- [By Monica Gerson]
VisionChina Media (NASDAQ: VISN) rose 33.40% to $32.27 after the company announced an exclusive strategic cooperation with Baidu Games.
ThermoGenesis (NASDAQ: KOOL) moved up 29.81% to $2.9857. ThermoGenesis' trailing-twelve-month revenue is $17.49 million.
Best Clean Energy Companies To Own For 2015: Federated Investors Inc. (FII)
Federated Investors, Inc. is a publicly owned investment manager. The firm provides its services to individuals, including high net worth individuals, banking or thrift institutions, investment companies, pension and profit sharing plans, pooled investment vehicles, charitable organizations, state or municipal government entities, and registered investment advisors. Through its subsidiaries, it manages separate client-focused equity, fixed income, and money market mutual funds and separate client-focused equity, fixed income, and balanced portfolios. The firm invests in the public equity and fixed income markets across the globe. It invests in growth and value stocks of small-cap, mid-cap, and large-cap companies. The firm makes its fixed income investments in ultra-short, short-term, and intermediate-term mortgage-backed, U.S. Government, U.S. Corporate, high yield, and municipal securities. It employs a fundamental and a quantitative analysis to make its equity investmen ts. The firm also makes sector-focused equity investments. Federated Investors was founded in 1955 and is based in Pittsburgh, Pennsylvania with an additional office in New York, New York.
Advisors' Opinion: - [By Jordan Wathen]
A federation of free cash flow
Federated Investors (NYSE: FII ) �also�looks appealing, even though its biggest business isn't contributing to the bottom line.
- [By Ben Levisohn]
But there are winners–and they’re any stock that’s helped by higher rates. There are mutual fund companies with big money-market fund businesses, who wouldn’t be forced to run these funds for what is essentially free. Federated Investors (FII), for instance, has jumped 2.1% to $27.99. Life insurance companies, too, are rising because they should be able to earn more on their investments. MetLife (MET), for instance, has risen 1.3% to $53.03.
Best Clean Energy Companies To Own For 2015: Cell Therapeutics Inc (CTIC)
Cell Therapeutics, Inc. (CTI), incorporated in 1991, develops, acquires and commercializes treatments for cancer. The Company�� research, development, acquisition and in-licensing activities concentrate on identifying and developing new ways to treat cancer. As of December 31, 2011, CTI focused its efforts on Pixuvri (pixantrone dimaleate) (Pixuvri), OPAXIO (paclitaxel poliglumex) (OPAXIO), tosedostat, brostallicin and bisplatinates. As of December 31, 2011, it developed Pixuvri, an anthracycline derivative for the treatment of hematologic malignancies and solid tumors. Another late-stage drug candidate of the Company, OPAXIO, is being studied as a potential maintenance therapy for women with advanced stage ovarian cancer, who achieve a complete remission following first-line therapy with paclitaxel and carboplatin. As of December 31, 2011, it also developed tosedostat in collaboration with Chroma Therapeutics, Ltd. (Chroma). On May 31, 2012, CTI completed its acquisition gaining worldwide rights to S*BIO Pte Ltd.'s (S*BIO) pacritinib.
Pixuvri
As of December 31, 2011, the Company developed Pixuvri, an aza-anthracenedione derivative, for the treatment of non-Hodgkin�� lymphoma (NHL), and various other hematologic malignancies, and solid tumors. Pixuvri was studied in the Company�� EXTEND, or PIX301, clinical trial, which was a phase III single-agent trial of Pixuvri for patients with relapsed, refractory aggressive NHL who received two or more prior therapies and who were sensitive to treatment with anthracyclines. On September 28, 2011, CTI announced that a second independent radiology assessment of response and progression endpoint data from its PIX301 clinical trial of Pixuvri was achieved with statistical significance. The results of the EXTEND trial met its primary endpoint and showed that patients randomized to treatment with Pixuvri achieved a significantly higher rate of confirmed and unconfirmed complete response compared to patients treated with standard chem! otherapy had a significantly increased overall response rate and experienced a statistically significant improvement in median progression free survival. Pixuvri had predictable and manageable toxicities when administered at the proposed dose and schedule in the EXTEND clinical trial in heavily pre-treated patients. In March 2011, the Company initiated the PIX-R trial to study Pixuvri in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). Pixuvri has also been studied in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens. In the second quarter of 2010, the NCCTG opened this phase II study for enrollment. The study is closed to accrual and results are expected to be reported by the NCCTG later in 2012.
OPAXIO
OPAXIO is the Company�� biologically-enhanced chemotherapeutic agent that links paclitaxel to a biodegradable polyglutamate polymer, resulting in a new chemical entity. As of December 31, 2011, the Company focused its development of OPAXIO on ovarian, brain, esophageal, head and neck cancer. OPAXIO was designed to improve the delivery of paclitaxel to tumor tissue while protecting normal tissue from toxic side effects. In November 2010, results were presented by the Brown University Oncology Group from a phase II trial of OPAXIO combined with temozolomide (TMZ), and radiotherapy in patients with newly-diagnosed, high-grade gliomas, a type of brain cancer. The trial demonstrated a high rate of complete and partial responses and a high rate of six month progression free survival (PFS). Based on these results, the Brown University Oncology Group has initiated a randomized, multicenter, phase II study of OPAXIO and standard radiotherapy versus TMZ and radiotherapy for newly diagnosed patients with glioblastoma with an active gene termed MGMT that reduces responsiveness to TMZ. A phase I/II study of OPAXIO combined with radi! otherapy ! and cisplatin was initiated by SUNY Upstate Medical University, in patients with locally advanced head and neck cancer.
Tosedostat
In March 2011, the Company entered into a co-development and license agreement with Chroma Therapeutics, Ltd. (Chroma), providing the Company with marketing and co-development rights to Chroma�� drug candidate, tosedostat, in North, Central and South America. Tosedostat is an oral, aminopeptidase inhibitor that has demonstrated anti-tumor responses in blood related cancers and solid tumors in phase I-II clinical trials. Interim results from the phase II OPAL study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia (AML) showed that once-daily, oral doses of tosedostat had predictable and manageable toxicities and results demonstrated response rates, including a high-response rate among patients who received prior hypomethylating agents, which are used to treat myelodysplastic syndrome (MDS), a precursor of AML.
Brostallicin
As of December 31, 2011, the Company developed brostallicin through its wholly owned subsidiary, Systems Medicine LLC, which holds rights to use, develop, import and export brostallicin. Brostallicin is a synthetic deoxyribonucleic acid (DNA) minor groove binding agent that has demonstrated anti-tumor activity and a favorable safety profile in clinical trials, in which more than 230 patients have been treated as of December 31, 2011. The Company uses a genomic-based platform to guide the development of brostallicin. A phase II study of brostallicin in relapsed, refractory soft tissue sarcoma met its predefined activity and safety hurdles and resulted in a first-line phase II clinical trial study that was conducted by the European Organization for Research and Treatment of Cancer (EORTC).
The Company competes with Bristol-Myers Squibb Company, Sanofi-Aventis, Pfizer, Roche Group, Genentech, Inc., Astellas Pharma, Eli Lilly and Company, Celgene, Telik, I! nc., TEVA! Pharmaceuticals Industries Ltd. and PharmaMar.
Advisors' Opinion: - [By Bryan Murphy]
Like it or not, all good things must come to an end.... even for a red hot stock like Cell Therapeutics Inc. (NASDAQ:CTIC). Yes, CTIC is up 111% since the end of 2013, up 14% today alone, and it doesn't look like the bulls have any reason to slow down now. That's exactly why now's the time for current shareholders to be afraid, however - expect it when you least expect it.
- [By John Udovich]
The start of 2014 shows that biotech is still a hot area with the sector along with small cap biotech stocks like AMAG Pharmaceuticals, Inc (NASDAQ: AMAG), Mast Therapeutics Inc (NYSEMKT: MSTX), Cell Therapeutics Inc (NASDAQ: CTIC), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and TNI BioTech (OTCMKTS: TNIB) producing news or returns�plus Auspex Pharmaceuticals (NASDAQ: ASPX), Cara Therapeutics (NASDAQ: CARA), Egalet (NASDAQ: EGLT), Flexion Therapeutics (NASDAQ: FLXN) and Ultragenyx Pharmaceutical (NASDAQ: RARE) are among the (many�� planned biotech IPOs that have recently been announced publicly:
Best Clean Energy Companies To Own For 2015: Mitek Systems Inc (MITK)
Mitek Systems, Inc. (Mitek), incorporated in 1986, is engaged in the development, sale and service of software solutions related to mobile imaging applications and intelligent recognition software. Mitek is applying its technology and in image correction, optical character recognition and intelligent data extraction to mobile devices. Using Mitek Mobile Apps, camera-equipped smartphone users can deposit checks, pay bills, save receipts and fax documents. Users simply take a picture of the document and its products corrects image distortion, extracting relevant data, routing images to their desired location, and processing transactions through users��financial institutions. It has developed and deployed Mobile Deposit, a software application that allows users to deposit a check using their smartphone camera. It has developed and deployed Mobile Receipt, a receipt archival and expense report application, and Mobile Phax, a mobile document faxing application. Its Mobile Photo Bill Pay, a mobile bill paying application that allows users to pay their bills using their smartphone camera. During fiscal year ended September 30, 2010 (fiscal 2010), it had one operating segment based on its product and service offerings.
IMagePROVE Technology Products
Using IMagePROVE, the Company has a suite of business productivity applications for camera-equipped smartphones, including the iPhone and selected BlackBerry, Android and Windows Mobile handsets. It has four products that use its IMagePROVE technology Mobile Deposit, Mobile Receipt, Mobile Phax and Mobile Photo Bill Pay. Its products are used in the financial services industry. It has secured sales partnerships with system integrators for the financial services industry, including Fiserv, FIS, NCR, Jack Henry, Wausau, BankServ, RDM, J&B Software and Bluepoint Solutions.
The Company�� Mobile Deposit is the smartphone application allows banks to accept check deposits through photos of checks taken with camera-equipped smart! phones. Mobile Deposit allows users to make deposits by photographing the front and back of a check and submitting the item electronically to their bank from their smartphone. Its Mobile Receipt is designed to convert the photo of a receipt taken with a smartphone into an image and with a single touch, converts the data into a professional looking expense report. Mobile Phax allows user to take a photo of any letter sized document or page and send it as a portable document format (PDF) file to any e-mail address or fax machine.
The Company�� Mobile Photo Bill Pay allows users to take pictures of their bills with their smartphone cameras and its Mobile Photo Bill Pay product correct image distortion, reading relevant data and processing the transactions through the users��banks. The payment is made electronically by debiting the users checking account and using existing online bill pay systems. With Mobile Photo Bill Pay, users can submit electronic payments from their smartphones without having to write checks, lick stamps, visit a payment location or even use their personal computers.
ImageNet Intelligent Character Recognition Toolkits
The Company�� ImageNet products are designed to provide remittance processing, proof of deposit and lock box processing applications. Its products are used to reduce manual labor by automatically extracting amounts and routing information from checks and distinguishing between common document types, such as personal and business checks, substitute checks, pre-authorized drafts and other document types specified by customers. It sells ImageNet suite of products to its channel partners, who resell them as integrated components of their solutions and services. Its ImageNet suite of products includes ImageNet Prep & ID, ImageNet Payments, ImageNet Data Capture and ImageNet Signatures.
ImageNet Prep & ID is a software toolkit that is designed to provide automatic form information document (ID), form registration and fo! rm/templa! te removal. Image Net Prep & ID reduces the image size by removing information, such as pre-printed text, lines, and boxes; leaving only the filled-in data. ImageNet Payments allows for the automatic reading of machine and hand print information found on scanned documents and forms from any structured form, as well as bank documents, such as checks, deposit slips, and remittance coupons. ImageNet Payments integrates technology components from the CheckReader product that it licenses from a vendor that is designed to read rates of the currency and legal amounts of checks drawn on the United States and Canadian financial institutions.
ImageNet Data Capture is a software toolkit that captures data from types of unstructured business documents. ImageNet Data Capture is used in data capture applications where data must be found and extracted from documents that have no pre-determined format or layout, but share common data elements. ImageNet Data Capture is designed to locate this data on documents using contextual, positional, format and keyword specific information. It has supplied ImageNet Data Capture as a stand alone application programming interface (API) to several original equipment manufacturers (OEMs) in the document processing field. ImageNet Signatures is a software toolkit that locates, extracts and verifies signatures in any document. It encodes each signature and compares it with encoded reference examples rather than comparing actual images. Its image analytics encode 60 characteristics of each signature, which allows for accurate signature fraud detection.
FraudProtect Systems
The Company�� FraudProtect System is an automated software application designed to allow banks to detect check fraud from forged signatures and counterfeit checks, as well as the detection of pre-authorized drafts and payee name alterations. Its FraudProtect suite of products includes FraudProtect SDK, PADsafe and PayeeFind. Its FraudProtect SDK is a toolkit designed to detect c! heck frau! d and forgery using image analytics to uncover inconsistencies and alterations in checks as they are processed by banks. These products are sold to OEMs and system integrators and can detect forged or illegally modified checks. Its PADsafe product detects fraudulent preauthorized drafts (PADs). PADsafe automatically identifies PADs from checks, and then notifies the user of fraudulent transactions, reducing and preventing the unauthorized withdrawal of funds. Its PayeeFind product is designed to prevent payee-altered checks from clearing.
ImageScore
ImageScore is the Company�� Check 21 readiness solution for any financial institution that truncates or uses check images in an accounts receivables conversion environment. Integrated solution providers for financial institutions can also buy ImageScore to enhance their products. ImageScore is designed to analyze check images to provide the usability and information needed to help financial institutions act in accordance with regulatory and industry mandates.
Advisors' Opinion: - [By Eric Volkman]
Mitek Systems (NASDAQ: MITK ) is hoping to widen its capital base. The company announced it is floating nearly 2.86 million shares of its common stock in an underwritten public flotation, at a price of $5.25 per share. Additionally, the company's underwriters have been granted a 30-day option to purchase up to 428,571 shares to cover overallotments, if any.
Best Clean Energy Companies To Own For 2015: Ishares Trust Dj Us Technology (IYW)
iShares Dow Jones U.S. Technology Sector Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Technology Index (the Index). The Index measures the performance of the technology sector of the United States equity market. The Index includes companies in industry groups, such as software and computer services, and technology hardware and equipment. The Index is a subset of the Dow Jones U.S. Total Market Index and is capitalization weighted. The Index is reconstituted quarterly.
The Fund will concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion: - [By Selena Maranjian]
The PowerShares QQQ ETF tracks the Nasdaq 100 Index, which is made up of 100 of the biggest stocks in the Nasdaq Stock Market based on market capitalization. It includes U.S. and international companies but excludes the financial industry and a few others. It's technology-heavy, featuring industries such as telecommunications, retail, biotechnology, and computer hardware and software. Compared to many other major technology-focused ETFs, such as the iShares US Technology ETF (NYSEMKT: IYW ) , this one is bigger, charges less in fees, and has a more impressive performance record. Its expense ratio, or annual fee, is a very low 0.2%, comparing favorably with many peers. It doesn't offer much of a dividend, as many of its holdings don't pay them.
